Literature DB >> 15249687

The human and African green monkey TRIM5alpha genes encode Ref1 and Lv1 retroviral restriction factor activities.

Zuzana Keckesova1, Laura M J Ylinen, Greg J Towers.   

Abstract

The rhesus macaque tripartite motif containing protein TRIM5alpha specifically restricts HIV-1 infection at an early post-entry step before reverse transcription [Stremlau, M., Owens, C. M., Perron, M. J., Kiessling, M., Autissier, P. & Sodroski, J. (2004) Nature 427, 848-853]. Here, we show that the human and African green monkey (AGM) TRIM5alpha genes encode Ref1 and Lv1 antiretroviral activities, respectively. Expression of TRIM5alpha in permissive cat cells renders them resistant to restriction-sensitive murine leukemia virus but not closely related insensitive virus. Disruption of TRIM5alpha expression in human and AGM cells with small interfering RNA rescues infectivity of restricted virus without affecting unrestricted virus. We also demonstrate that the activity of the murine restriction factor Fv1 depends on TRIM5alpha expression when Fv1 is expressed in human cells. Furthermore, a drug that modifies the behavior of the related promyelocytic leukemia protein PML specifically rescues infection by viruses restricted by human TRIM5alpha. Alignment of the TRIM5alpha proteins from rhesus macaque and AGM indicates an 18-aa insertion. We speculate that this insertion may contribute to the broader specificity of the AGM TRIM5alpha restriction as compared with the human and rhesus macaque proteins.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15249687      PMCID: PMC490011          DOI: 10.1073/pnas.0402474101

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  43 in total

1.  Protein fold analysis of the B30.2-like domain.

Authors:  M H Seto; H L Liu; D A Zajchowski; M Whitlow
Journal:  Proteins       Date:  1999-05-01

2.  Biological studies on a lymphoid-leukemia virus extracted from sarcoma 37. I. Origin and introductory investigations.

Authors:  J B MOLONEY
Journal:  J Natl Cancer Inst       Date:  1960-04       Impact factor: 13.506

3.  Clonal cells lines from a feral mouse embryo which lack host-range restrictions for murine leukemia viruses.

Authors:  J W Hartley; W P Rowe
Journal:  Virology       Date:  1975-05       Impact factor: 3.616

4.  Synthesis and circularization of N- and B-tropic retroviral DNA Fv-1 permissive and restrictive mouse cells.

Authors:  W K Yang; J O Kiggans; D M Yang; C Y Ou; R W Tennant; A Brown; R H Bassin
Journal:  Proc Natl Acad Sci U S A       Date:  1980-05       Impact factor: 11.205

5.  Arsenic-induced PML targeting onto nuclear bodies: implications for the treatment of acute promyelocytic leukemia.

Authors:  J Zhu; M H Koken; F Quignon; M K Chelbi-Alix; L Degos; Z Y Wang; Z Chen; H de Thé
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-15       Impact factor: 11.205

6.  Species-specific, postentry barriers to primate immunodeficiency virus infection.

Authors:  W Hofmann; D Schubert; J LaBonte; L Munson; S Gibson; J Scammell; P Ferrigno; J Sodroski
Journal:  J Virol       Date:  1999-12       Impact factor: 5.103

7.  Single amino acid changes in the murine leukemia virus capsid protein gene define the target of Fv1 resistance.

Authors:  C A Kozak; A Chakraborti
Journal:  Virology       Date:  1996-11-15       Impact factor: 3.616

8.  Effect of Fv-1 gene product on synthesis of linear and supercoiled viral DNA in cells infected with murine leukemia virus.

Authors:  P Jolicoeur; E Rassart
Journal:  J Virol       Date:  1980-01       Impact factor: 5.103

9.  Positional cloning of the mouse retrovirus restriction gene Fv1.

Authors:  S Best; P Le Tissier; G Towers; J P Stoye
Journal:  Nature       Date:  1996-08-29       Impact factor: 49.962

10.  A major genetic locus affecting resistance to infection with murine leukemia viruses. II. Apparent identity to a major locus described for resistance to friend murine leukemia virus.

Authors:  T Pincus; W P Rowe; F Lilly
Journal:  J Exp Med       Date:  1971-06-01       Impact factor: 14.307

View more
  201 in total

1.  Modulation of TRIM5alpha activity in human cells by alternatively spliced TRIM5 isoforms.

Authors:  Emilie Battivelli; Julie Migraine; Denise Lecossier; Saori Matsuoka; Danielle Perez-Bercoff; Sentob Saragosti; François Clavel; Allan J Hance
Journal:  J Virol       Date:  2011-06-01       Impact factor: 5.103

2.  In defense of the cell: TRIM5alpha interception of mammalian retroviruses.

Authors:  Kyeongeun Lee; Vineet N KewalRamani
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-13       Impact factor: 11.205

3.  A Trim5-cyclophilin A fusion protein found in owl monkey kidney cells can restrict HIV-1.

Authors:  Sébastien Nisole; Clare Lynch; Jonathan P Stoye; Melvyn W Yap
Journal:  Proc Natl Acad Sci U S A       Date:  2004-08-23       Impact factor: 11.205

4.  RING domain mutations uncouple TRIM5α restriction of HIV-1 from inhibition of reverse transcription and acceleration of uncoating.

Authors:  Amanda Roa; Fumiaki Hayashi; Yang Yang; Maritza Lienlaf; Jing Zhou; Jiong Shi; Satoru Watanabe; Takanori Kigawa; Shigeyuki Yokoyama; Christopher Aiken; Felipe Diaz-Griffero
Journal:  J Virol       Date:  2011-11-23       Impact factor: 5.103

Review 5.  Emerging drug targets for antiretroviral therapy.

Authors:  Jacqueline D Reeves; Andrew J Piefer
Journal:  Drugs       Date:  2005       Impact factor: 9.546

6.  Leveraging APOBEC3 proteins to alter the HIV mutation rate and combat AIDS.

Authors:  Judd F Hultquist; Reuben S Harris
Journal:  Future Virol       Date:  2009-11-01       Impact factor: 1.831

Review 7.  Molecular evolution of the antiretroviral TRIM5 gene.

Authors:  Welkin E Johnson; Sara L Sawyer
Journal:  Immunogenetics       Date:  2009-02-24       Impact factor: 2.846

8.  Analysis of human cell heterokaryons demonstrates that target cell restriction of cyclosporine-resistant human immunodeficiency virus type 1 mutants is genetically dominant.

Authors:  Chisu Song; Christopher Aiken
Journal:  J Virol       Date:  2007-08-22       Impact factor: 5.103

9.  A single amino acid of the human immunodeficiency virus type 2 capsid affects its replication in the presence of cynomolgus monkey and human TRIM5alphas.

Authors:  Haihan Song; Emi E Nakayama; Masaru Yokoyama; Hironori Sato; Jay A Levy; Tatsuo Shioda
Journal:  J Virol       Date:  2007-05-02       Impact factor: 5.103

10.  An expanded clade of rodent Trim5 genes.

Authors:  Semih U Tareen; Sara L Sawyer; Harmit S Malik; Michael Emerman
Journal:  Virology       Date:  2009-01-15       Impact factor: 3.616

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.